Chandran, Manju http://orcid.org/0000-0001-9119-8443
Brind’Amour, Katherine
Fujiwara, Saeko
Ha, Yong-Chan
Tang, Hai
Hwang, Jawl-Shan
Tinker, James
Eisman, John A.
Funding for this research was provided by:
Amgen
Article History
Received: 15 June 2022
Accepted: 21 December 2022
First Online: 3 February 2023
Declarations
:
: For this type of study, formal consent is not required.
: • MC has received honoraria from DKSH, Amgen, and Kyowa Kirin for chairing advisory boards and for speaking engagements.• KB received funding from Amgen to lead the protocol development, oversee the systematic review research and data abstraction, and organize and interpret the data for publication. She has research and marketing consulting and medical writing contract relationships with numerous medical communications and consulting agencies, and therefore indirectly receives compensation from many pharmaceutical companies for her work on clinical trial endpoints, clinician education, medical communications, and medical marketing.• SF, JH, YH, and HT have no interests to declare.• JT received funding from Amgen to lead the protocol development, oversee the systematic review research and data abstraction, and organize the data for publication.• JE has received research funding and consulting fees from Amgen, Lilly, MSD, and Theramex, and has served on advisory boards for Amgen and Theramex.